Transparency Market Research
This presentation is the property of its rightful owner.
Sponsored Links
1 / 6

Anti-cancer Drugs Market Set to Expand by 2024 PowerPoint PPT Presentation

  • Uploaded on
  • Presentation posted in: Industry

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Anti-cancer Drugs Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Read Full Report:

Download Presentation

Anti-cancer Drugs Market Set to Expand by 2024

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

Anti cancer drugs market set to expand by 2024

Transparency Market Research

Single User License:

USD 4315.5

 

Flat 10% Discount!!

 

Free Customization as per your requirement

 

You will get Custom Report at Syndicated Report


 

Report will be delivered with in 15-20 working days

Anti-cancer Drugs Market - Global

Industry Analysis, Size, Share,

Growth, Trends, and Forecast 2016 -


Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

[email protected]


Request Sample

Buy Now

Anti cancer drugs market set to expand by 2024


Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Anti-cancer

Drugs Market". This report likewise incorporates more illumination about fundamental review of the business including

definitions, requisitions and worldwide business sector industry structure.

Global Anti-cancer Drugs Market: Overview

The World Cancer Research Fund states that in 2012, there were around 14 million new cases of cancer around the world; of

these, women accounted for 6.7 million cases and men accounted for 7.4 million cases. This figure is likely to increase to 24

million by 2035. Similarly, according to the World Health Organization, an estimated 8.2 million deaths in 2012 were directly

related to cancer and the number of new cancer cases is anticipated to increase by an estimated 70% over the next two

decades. Accounting for 13% of the total number of new cases diagnosed in 2012, lung cancer was the most common cancer

across the globe, followed by breast cancer (1.7 million new cases), and colorectal cancer (1.4 million new cases).

Browse Full Report with TOC:

Cancer mortality can be reduced if the disease is detected and treated early. Timely and correct diagnosis is key to effective and

adequate treatment. Today, the global anti-cancer drugs market can be rightly characterized by the enormous amount of

innovation that hopes to transform the landscape for patients, providers, and companies alike. SEER (Surveillance,

Epidemiology, and End Results) survival statistics reveal that in 1990, only half of all cancer patients lived for five years after

diagnosis. This has now increased to two-thirds, a result of gradual but consistent innovation in the anti-cancer drugs market.

This research report serves as a blueprint for all stakeholders in the anti-cancer drugs market as it not only gives them a fresh,

objective, and accurate perspective of the global industry but also examines the key factors governing its growth from 2016 to

2024, the report’s forecast period. Leading trends, forces driving the growth, and challenges that lie ahead have been discussed

at length, supported by appropriate statistics and inputs from industry experts.

Global Anti-cancer Drugs Market: Key Trends and Opportunities

Anti cancer drugs market set to expand by 2024

The rising global incidence of various cancers, including cancer of the breast, prostate, skin, blood, gastrointestinal tract, and

lungs, is the primary factor boosting the demand for anti-cancer drugs. In addition to this, the development of advanced

therapeutic modalities, such as targeted therapies, chemotherapy, immunotherapy, and hormonal therapies has significantly

benefited the anti-cancer drugs market in recent years.

This market is predicted to benefit from the commercialization of follow-on-biologics and patent expiration of several

blockbuster drugs. The threat of failure of the drugs, the high cost involved in the development of anti-cancer drugs, and the

possible side effects of these drugs are expected to challenge the expansion of the global market in the coming years. However,

rising government funds are likely to reduce the negative impact of these obstacles and continue propelling the anti-cancer

drugs market.

Global Anti-cancer Drugs Market: Competitive Landscape and Region-wise Outlook

Some of the most prominent players in the global anti-cancer drugs market are Celgene Corporation, Eli Lilly and Company,

Roche Diagnostics, Novartis AG, Pfizer, Sanofi, Amgen Inc., GlaxoSmithKline PLC, Merck & Company, and Johnson and Johnson.

Geographically, the international market for anti-cancer drugs is segmented into North America, Europe, Asia Pacific, and Rest of

the World. North America presently surpasses all of the aforementioned regional markets and is likely to retain its leading

position throughout the duration of the forecast period. Favorable reimbursement policies, the surge in investments by

prominent multinational companies in the research as well as development of anti-cancer drugs, and the high adoption rate of

immunotherapies are some of the major factors responsible for the growth of the North America anti-cancer drugs market.

Asia Pacific has been identified as a rather lucrative region for the anti-cancer drugs market owing to the rising awareness

regarding the availability of advanced therapies. The increase in healthcare expenditure and per capita disposable income is

also likely to contribute toward the future expansion of the Asia Pacific anti-cancer drugs market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and

verifiable projections about market size. The projections featured in the report have been derived using proven research

methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every

facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Anti cancer drugs market set to expand by 2024

Download Brochure for this Report:


The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)

Anti cancer drugs market set to expand by 2024

Middle East and Africa (GCC, Southern Africa, North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned

analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The

report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and

market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and

mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment

over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market

Important changes in market dynamics

Market segmentation up to the second or third level

Historical, current, and projected size of the market from the standpoint of both value and volume

Reporting and evaluation of recent industry developments

Market shares and strategies of key players

Emerging niche segments and regional markets

An objective assessment of the trajectory of the market

Recommendations to companies for strengthening their foothold in the market

Anti cancer drugs market set to expand by 2024

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our

exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision


We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and

various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most

reliable information indispensable for businesses to sustain a competitive edge.


Transparency Market Research

90 State Street,

Suite 700,


NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: [email protected]


  • Login